It turns out GGCT expression level remains as significant prognostic markers for clinical outcomes in patients (Table 3), suggesting that GGCT could potentially be used as a prognostic indicator for pancreatic cancer prognosis. The gene discussed is GGCT; the disease is familial pancreatic carcinoma.